- 10:30 AM Buy GVK Power, says VK Sharma
- 10:19 AM Buy HOEC on all declines: Mitesh Thacker
- 10:13 AM Book profit in Sesa Goa at Rs 340: Thacker
- 10:04 AM SEBI bars Pyramid Saimira for 7yrs in IPO irregula...
- 09:58 AM Pantaloon Retail may slip to Rs 265: Thacker
- 09:56 AM Sensex flat; SBI, ICICI Bank, DLF, HDFC, RComm dip
- 09:55 AM Mkt may trade sideways on quiet global cues: Udaya...
- 09:54 AM State Trading Corporation can test Rs 425: M Thack...
- 09:51 AM Buy ITI with stoploss of Rs 45.50: M Thacker
- 09:49 AM Nifty has resistance at 4945-4950: Reliance Sec
Sun Pharma today announced that it had received tentative approval from the USFDA for Amifostine for injection 500mg, filed from its site in India.
Amifostine is used as an adjuvant in cancer treatment. Sun Pharma’s amifostine injection will be indicated for the reduction of kidney damage in patients who have advanced ovarian cancer and are being given repeat doses of cisplatin.
Ethyol is currently covered under 3 patents-‘471 (July 31,2012), ‘731 (July 31,2012) and ‘409 (Dec 8,2017). Sun Pharma filed an ANDA with para IV certification against all the patents. Medimmune filed a suit against Sun Pharma in the District Court of Maryland. Sun Pharma has filed a motion for summary judgment for non–infringement.
Sun Pharma markets this product in India based on the formulation developed at its R&D center, SPARC. Sun Pharma is completely integrated for this product and manufactures the API at its plant in Ahmednagar.
Sourced From: Sun Pharmaceutical Industries Ltd
|
|
Today's Special Column
with Ashok Gulati
International Food Policy Research Institute , Director in Asia
-
Most Read
-
Most Viewed
- 10 companies that MF managers love
- 10 Companies that FIIs love
- Experts on stocks and sectors to pick/avoid now
- Sensex may drift down to 12500, -ve on RIL: Shankar Sharma
- IPO scam: SEBI bars Pyramid Saimira for 7 years
- Ganeshaspeaks: Market prediction for Nov 11
- Mitesh Thacker's top picks for today's trade
- What are Ashish Chugh's hidden gems for Nov?
- Buy HOEC on all declines: Mitesh Thacker
Source: CNBC-TV18
- Book profit in Sesa Goa at Rs 340: Thacker
Source: CNBC-TV18
- SEBI bars Pyramid Saimira for 7yrs in IPO irregularity case
Source: Moneycontrol.com
- Pantaloon Retail may slip to Rs 265: Thacker
Source: CNBC-TV18
- Kochi port urges Govt to lift palm oil import ban
Source: Business Line
- Punj Lloyd signs JV agreement with Delta Solar
Source: Business Line
- IL&FS renegotiates Maytas Infra debt package with lenders
Source: Business Line
- Neyveli Lignite to set up wind power project
Source: Business Line
